National Health Act 1953 Amendment determination under subsections 85AB(1) and 85ac(1) drugs on F1 and drugs in Part A of F2 (No. PB 83 of 2008) (Cth)

COMMONWEALTH OF AUSTRALIA

Instrument number PB 83 of 2008

Amendment determination under subsections 85AB(1) and 85AC(1) of the National Health Act 1953

I, DIANA MACDONELL, Acting Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under subsections 85AB(1) and 85 AC(1) of the National Health Act 1953.

Dated    9^th July    2008

DIANA MACDONELL

Acting Assistant Secretary

Pharmaceutical Evaluation Branch

Department of Health and Ageing

Determination – drugs on F1 and drugs in Part A of F2    

1.         Commencement

This instrument commences on 1 August 2008.

2.         Amendment of PB 95 of 2007

Schedule 1 amends PB 95 of 2007.

Schedule 1   Amendments

[1]       Paragraph 2, Drugs on F1, after “Darunavir”,.

insert:

“Erlotinib”, “Fludarabine”,

[2]       Paragraph 2, Drugs on F1, after “Lapatinib”

(a) omit the word:

and

(b) insert:

, “Nilotinib”,

[3]       Paragraph 2, Drugs on F1, after “Sevelamer”

insert:

, “Sitagliptin” and “Telbivudine”

[4]       Paragraph 3, Drugs on F2

insert after “The listed drugs”:

“Bicalutamide”, “Cefalotin”,

[5]       Paragraph 4, Drugs in Part A of F2

insert as first entries:

“Bicalutamide”, “Cefalotin”,